| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |